Novo Nordisk (Ozempic)
Acquired
00:00
Complexity of the Value Chain in the US Healthcare Market
Understanding the value chain of the US healthcare market is challenging due to its complexity. The process involves multiple key players such as manufacturers, distributors, pharmacies, and consumers. While it may seem like a straightforward retail supply chain where a patient buys a drug, the reality is more intricate. Manufacturers like Novo Nordisk develop drugs sold to distributors like McKesson or Cardinal Health, who then supply pharmacies like CVS. When a customer purchases a drug from the pharmacy, they typically don't directly pay the price set at the register. This system is unique to the US market and may seem convoluted to those in other regions.
Transcript
Play full episode
